The human microbiome contains between 10 and 100 trillion micro-organisms, including bacteria, archaea, and viruses. Studies linking changes in the composition and function of the microbiome with both normal and pathological outcomes have led to the emergence of a market dedicated to targeting the microbiome with the goal of preventing and treating disease. Understanding this market may help researchers and companies determine whether they could have a role to play in it.
This whitepaper provides an overview of recent developments in the microbiome therapeutics market with a focus on current research trends, major investment events, and market opportunities.
To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content.
Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.
Log in or Create an Informa Connect Account to Access this content
Creating an account also means you'll get special access to article updates and exclusive industry content.